Intalere Members Benefit from Agreement with Amneal Pharmaceuticals
St. Louis (October 10, 2019) – Intalere Choice, the preferred portfolio subsidiary of Intalere, announces a new agreement with Amneal Pharmaceuticals.
Through this agreement Intalere members will receive negotiated pricing on quality generic and specialty medicines. The Amneal generics portfolio, which includes more than 300 medicines along with specialty medications, provides patients with more affordable access to quality medication options.
This contract is currently effective through September 30, 2020.
About Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States. Amneal has an extensive portfolio of more than 300 generic medicines and is expanding its portfolio to include complex dosage forms in a broad range of therapeutic areas. The company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.
Intalere’s mission focuses on improving the operational health of America’s healthcare providers by designing tailored, smart solutions that deliver optimal cost, quality and clinical outcomes. We strive to be the essential partner for operational excellence in healthcare through customized solutions that address customers’ individual needs. We assist our customers in managing their entire spend, providing innovative technologies, products and services, and leveraging the best practices of a provider-led model. As Intalere draws on the power of our owner Intermountain Healthcare’s nationally-recognized supply chain expertise and leadership in technology, process improvement, and evidence-based clinical and business best practices, we are uniquely positioned to be the innovation leader in the healthcare industry. Visit www.intalere.com to learn more.